Insurances.net
insurances.net » Global Economy » Avoiding FDA 483 Observations by Identifying the Root Cause of Deviations - Webinar By GlobalCompliancePanel
Home Business Small Business Wholesale Business Business agency Global Economy
]

Avoiding FDA 483 Observations by Identifying the Root Cause of Deviations - Webinar By GlobalCompliancePanel

Avoiding FDA 483 Observations by Identifying the Root Cause of Deviations - Webinar By GlobalCompliancePanel


Overview: Recent Consent Decrees have included requirements that the firm develop and implement systems that result in timely and complete investigations of deviations and corrective and preventive actions that address the root cause of deviations.

FDA 483 and Warning letter observations identify inadequate investigations and follow-up. This webinar addresses adequate investigation of deviations.Participants will obtain a greater insight into effective investigations and ways to identify the root cause and prevent a similar deviation in the future.

The investigation of deviations is clearly a US FDA expectation.The international regulatory expectation for a structured approach to investigations that lead to corrective actions and preventive actions is clearly stated in ICH Q10, Pharmaceutical Quality System, and supported in the FDA Guidance to the Industry, Quality System Approach to Pharmaceutical CGMP Regulations. This course will include a discussion of the Deviation System, what should be investigated and the level of investigation. Several tools that will lead to the identification of the root cause will be discussed. These include: process mapping, brainstorming, cause analysis, cause and effect and the 5 Whys. The investigation system will be integrated with the CAPA and Change Control Systems.

Why you should attend: Recent Consent Decrees have included requirements that the firm develop and implement systems that result in timely and complete investigations of deviations and corrective and preventive actions that address the root cause of deviations. FDA 483 and Warning letter observations identify inadequate investigations and follow-up. This webinar addresses adequate investigation of deviations.Participants will obtain a greater insight into effective investigations and ways to identify the root cause and prevent a similar deviation in the future.

The investigation of deviations is clearly a US FDA expectation.The international regulatory expectation for a structured approach to investigations that lead to corrective actions and preventive actions is clearly stated in ICH Q10, Pharmaceutical Quality System, and supported in the FDA Guidance to the Industry, Quality System Approach to Pharmaceutical CGMP Regulations. This course will include a discussion of the Deviation System, what should be investigated and the level of investigation. Several tools that will lead to the identification of the root cause will be discussed. These include: process mapping, brainstorming, cause analysis, cause and effect and the 5 Whys. The investigation system will be integrated with the CAPA and Change Control Systems.

Areas Covered in the Session: What should be investigated - Complaints, audit observations, deviations, discrepancies, calibration out-of-tolerances

FDA expectations for investigations

The investigation-problem resolution process - understand the problem, identify possible causes, data collection, data analysis, root cause identification, root cause elimination, solution implementation, verify success

Tools for understanding the process - mapping, critical incident, performance matrix

Tools for understanding the possible causes - brainstorming, is/is not, nominal group

Tools for narrowing the investigation to the most probable cause - data collection, data analysis

Determining the root cause - cause and effect, Fault tree, 5 Whys.

Corrective action

Preventive Action

Verification

Who will benefit: The following individuals and disciplines will benefit from this webinar: QA document reviewers

QA personnel responsible for reviewing investigations reports

QA personnel responsible for the deviation and investigations systems

Quality and Operations personnel responsible for investigations

Personnel from all units responsible for initiating investigations
High Definition Television Purchasing Guide Why Plastic Shipping Boxes May Be Your Only Option Marine: Global Industry Guide Global Vaccine Market Forecast To 2012 Shipping Boxes For Sale - Where You Can Find The Perfect Boxes For You Fiber Optic Fusion Splicer Global Market Forecast (2009-2014) Leds Used In Signage & Professional Displays Global Market Forecast (2009-2015) High Brightness Light Emitting Diodes (hb-leds) Global Market Forecast & Analysis 2009-2015 Hassle Free Purchasing To Get Big and Tall Mens Attire How the Fed Could Save the Economy and Destroy the Currency Cheap International Calls- Minimize Your Phone Bills, Maximize Your Global Contacts The Global Bottled Water Report - 2010 Middle East North Africa --- Aarkstore Enterprise The Impact Of Cheap Custom Stickers On Global Industries
Write post print
www.insurances.net guest:  register | login | search IP(52.14.20.147) Washington / Seattle Processed in 0.013661 second(s), 6 queries , Gzip enabled debug code: 40 , 4126, 465,
Avoiding FDA 483 Observations by Identifying the Root Cause of Deviations - Webinar By GlobalCompliancePanel Seattle